BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities
July 10, 2026
Technology
-
-
SEALSQ and Quobly Sign $5 Million Commercial Agreement to Integrate Post-Quantum Security into Next-Generation Silicon Quantum Computing Platforms
July 10, 2026
-
Perfect Corp. Enters into a Definitive Agreement for a Going-Private Transaction
July 10, 2026
-
Sphere 3D Advances AI Infrastructure Strategy with New Investor Relations and Government Relations Partners
July 10, 2026
-
IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx(TM) DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma
July 9, 2026
-
Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics
July 9, 2026
-
BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities
July 8, 2026
-
Beyond the Flock Backlash: Rekor Publishes Privacy and Evidence Architecture for Responsible Vehicle Recognition
July 8, 2026
-
Perfect Corp. Showcases AI Skin, Beauty and Fashion APIs and Launches Global Hackathon at WeAreDevelopers Berlin 2026
July 8, 2026
-
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
July 8, 2026
-
Evogene and Tel Aviv University’s Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery
July 8, 2026
-
Intermap Expands Aquarius RMA Platform with Property Valuation Analytics and Accelerates European Growth
July 8, 2026
-
Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program
July 7, 2026
-
authID Announces Strategic Partnership with SynerComm to Expand Biometric Identity Security Across Highly Regulated Enterprises
July 7, 2026
-
Snowflake Expands Role in Enterprise AI Readiness
July 7, 2026
-
AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026
July 7, 2026